Amy N. Luckenbaugh

3.3k total citations · 4 hit papers
66 papers, 1.8k citations indexed

About

Amy N. Luckenbaugh is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Amy N. Luckenbaugh has authored 66 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 21 papers in Surgery and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Amy N. Luckenbaugh's work include Prostate Cancer Diagnosis and Treatment (15 papers), Bladder and Urothelial Cancer Treatments (13 papers) and Diversity and Career in Medicine (12 papers). Amy N. Luckenbaugh is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (15 papers), Bladder and Urothelial Cancer Treatments (13 papers) and Diversity and Career in Medicine (12 papers). Amy N. Luckenbaugh collaborates with scholars based in United States, Canada and Georgia. Amy N. Luckenbaugh's co-authors include Melissa Tobin, Jill A. Kanaley, Vincent Frechette, Robert Carhart, Scott R. Collier, Todd M. Morgan, Christopher J.D. Wallis, Jonathan Fainberg, Lorelei A. Mucci and Kelly R. Pekala and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Amy N. Luckenbaugh

59 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review

2023 379 citations Amy N. Luckenbaugh et al. European Urology profile →
Association of Surgeon-Patient Sex Concordance With Postoperative Outcomes

2021 211 citations Christopher J.D. Wallis, Zachary Klaassen et al. profile →
Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer

2020 183 citations Karen E. Hoffman, David F. Penson et al. profile →
Surgeon Sex and Long-Term Postoperative Outcomes Among Patients Undergoing Common Surgeries

2023 95 citations Christopher J.D. Wallis, Zachary Klaassen et al. profile →

Peers

Countries citing papers authored by Amy N. Luckenbaugh

Since Specialization

Citations

This map shows the geographic impact of Amy N. Luckenbaugh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy N. Luckenbaugh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy N. Luckenbaugh more than expected).

Fields of papers citing papers by Amy N. Luckenbaugh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy N. Luckenbaugh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy N. Luckenbaugh. The network helps show where Amy N. Luckenbaugh may publish in the future.

Co-authorship network of co-authors of Amy N. Luckenbaugh

This figure shows the co-authorship network connecting the top 25 collaborators of Amy N. Luckenbaugh. A scholar is included among the top collaborators of Amy N. Luckenbaugh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy N. Luckenbaugh. Amy N. Luckenbaugh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gender equity in oncology: Progress, challenges, and the path forward in urologic oncology and oncologic specialties 2025 ·Cancer ·(unknown), (unknown), Amy N. Luckenbaugh, Lindsey A. Herrel	1
2	Extensive necrosis as a prognostic indicator in metastatic RCC patients undergoing deferred cytoreductive nephrectomy after immunologic checkpoint inhibitor treatment. 2025 ·Journal of Clinical Oncology ·(unknown), (unknown), (unknown), Kelvin A. Moses, Jennifer Gordetsky, Sam S. Chang, Amy N. Luckenbaugh, Kristin Kathleen Ancell, (unknown), Kerry Schaffer, (unknown), Daniel Joyce, Brian I. Rini	0
3	Low-cost and label-free blue light cystoscopy through digital staining of white light cystoscopy videos 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), Kristen R. Scarpato, Amy N. Luckenbaugh, Sam S. Chang, Soheil Kolouri, Audrey K. Bowden	0
4	Automated Upper Tract Urothelial Carcinoma Tumor Segmentation During Ureteroscopy Using Computer Vision Techniques 2024 ·Journal of Endourology ·(unknown), Amy E. McCart Reed, Natalie Pace, Amy N. Luckenbaugh, Maximilian Pallauf, Nirmish Singla, İpek Oğuz, Nicholas Kavoussi	4
5	On the shoulders of giants: correlation of rates of female first authorship with senior authorship gender 2022 ·British journal of surgery ·(unknown), Rashid K. Sayyid, Zachary Klaassen, (unknown), Diana Magee, Amy N. Luckenbaugh, Christopher J.D. Wallis	4
6	Incorporating Prostate-specific Membrane Antigen Positron Emission Tomography in Management Decisions for Men with Newly Diagnosed or Biochemically Recurrent Prostate Cancer 2022 ·European Urology ·Laura Bukavina, Amy N. Luckenbaugh, Michael S. Hofman, (unknown), Sophia C. Kamran, Declan G. Murphy, Kosj Yamoah, Piet Ost	19
7	Association between prior nephrectomy and efficacy of immune checkpoint inhibitor therapy in metastatic renal cell carcinoma - A systematic review and meta-analysis 2021 ·Urologic Oncology Seminars and Original Investigations ·Raj Satkunasivam, (unknown), Zachary Klaassen, Mary E. Hall, Amy N. Luckenbaugh, (unknown), (unknown), Antonio P. DeRosa, Kathryn E. Beckermann, Brian I. Rini, Christopher J.D. Wallis	1
8	Association of Treatment Modality, Functional Outcomes, and Baseline Characteristics With Treatment-Related Regret Among Men With Localized Prostate Cancer 2021 ·JAMA Oncology ·Christopher J.D. Wallis, Zhiguo Zhao, Li‐Ching Huang, David F. Penson, Tatsuki Koyama, Sherrie H. Kaplan, Sheldon Greenfield, Amy N. Luckenbaugh, Zachary Klaassen, Ralph Conwill, Michael Goodman, Ann S. Hamilton, Xiao‐Cheng Wu, Lisa E. Paddock, Antoinette M. Stroup, Matthew R. Cooperberg, Mia Hashibe, Brock B. O’Neil, Karen E. Hoffman, Daniel A. Barocas	54
9	Association between cytoreductive nephrectomy and survival among patients with metastatic renal cell carcinoma receiving modern therapies: a systematic review and meta-analysis examining effect modification according to systemic therapy approach 2021 ·Cancer Causes & Control ·Mary E. Hall, Bimal Bhindi, Amy N. Luckenbaugh, (unknown), Kelvin A. Moses, Raj Satkunasivam, Brian I. Rini, Zachary Klaassen, Christopher J.D. Wallis	7
10	Association Between Surgical Volume and Survival Among Patients With Variant Histologies of Bladder Cancer 2021 ·Urology ·Wilson Sui, Mary E. Hall, Daniel A. Barocas, Sam S. Chang, Amy N. Luckenbaugh, Kelvin A. Moses, David F. Penson, Christopher J.D. Wallis, Aaron A. Laviana	2
11	Racial disparities in mortality for patients with prostate cancer after radical prostatectomy 2020 ·Cancer ·Wanqing Wen, Amy N. Luckenbaugh, (unknown), David F. Penson, Xiao‐Ou Shu	26
12	<p>Metastatic Hormone-sensitive Prostate Cancer: Current Perspective on the Evolving Therapeutic Landscape</p> 2020 ·OncoTargets and Therapy ·Mary E. Hall, (unknown), Amy N. Luckenbaugh, Aaron A. Laviana, Kirk A. Keegan, Zachary Klaassen, Kelvin A. Moses, Christopher J.D. Wallis	19
13	High-Risk Nonmuscle Invasive Bladder Cancer: Selecting the Appropriate Patient for Timely Cystectomy 2020 ·Urology ·(unknown), Amy N. Luckenbaugh, Sam S. Chang	2
14	Adjuvant Versus Salvage Radiotherapy Following Radical Prostatectomy: Meta-analysis of the Effect of Comparator Salvage Approach on Study Conclusions 2019 ·European Urology ·Christopher J.D. Wallis, Zachary Klaassen, Amy N. Luckenbaugh, Aaron A. Laviana, Bimal Bhindi	0
15	Leveraging the clinical collaborative model to drive value improvement 2018 ·Current Opinion in Urology ·Amy N. Luckenbaugh, Gregory B. Auffenberg	2
16	A Management Algorithm for Mitomycin C Induced Cystitis 2017 ·Bladder Cancer ·Amy N. Luckenbaugh, Rory M. Marks, David C. Miller, Alon Z. Weizer, John T. Stoffel, Jeffrey S. Montgomery	6
17	Determining Resident Sleep During and After Call With Commercial Sleep Monitoring Devices 2017 ·Urology ·Duncan Morhardt, Amy N. Luckenbaugh, Cathy Goldstein, Gary J. Faerber	9
18	Collaborative quality improvement 2017 ·Current Opinion in Urology ·Amy N. Luckenbaugh, David C. Miller, Khurshid R. Ghani	12
19	Using Analytic Morphomics to Understand Short-Term Convalescence after Radical Cystectomy 2016 ·Bladder Cancer ·Amy N. Luckenbaugh, Brent K. Hollenbeck, Jeffrey S. Montgomery, Cheryl T. Lee, Scott M. Gilbert, Rodney L. Dunn, Jeffrey F. Friedman, Michael J. Englesbe, Stewart C. Wang, John M. Hollingsworth	3
20	Cardiac autonomic function and baroreflex changes following 4 weeks of resistance versus aerobic training in individuals with pre‐hypertension 2008 ·Acta Physiologica ·Scott R. Collier, Jill A. Kanaley, Robert Carhart, Vincent Frechette, Melissa Tobin, Nathan Bennett, Amy N. Luckenbaugh, Bo Fernhall	97

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact